NOV 15, 2018 11:39 AM PST

Treating Restless Leg Syndrome (RLS)

WRITTEN BY: Nouran Amin

Credit: verywellhealth.com

A common condition of the nervous system, Restless Leg Syndrome (RLS) is the overwhelming urge to move the legs. Usually unpleasant symptoms, many RLS patients experience tingling, burning and painful cramping sensations in the leg—with 80% experience usually at bedtime their legs jerking or twitching.

Now, according to a study published in the Journal of Physiology, a breakthrough treatment for RLS may be on its way.

Recent research is pointing that RLS may not just be caused by simply genetics and the central nervous system but by the nerve cells targeting the muscles. The researchers were able to conclude their findings after measuring the nerve excitability in motor nerve cells of patients with RLS and compared these measurements to healthy subjects.

Specifically, the study indicates that the involuntary muscle moments in RLS are actually caused by an increased number of signals between nerve cells that supply the leg muscles. Such discovery could prompt researchers working in drug development and discovery to find more targeted treatments for RLS.

Credit: heathjade.com

“Patients who suffer from Restless legs syndrome complain of painful symptoms in the legs leading to sleep disturbances. The mechanisms for RLS are still not completely understood. We have shown that also the nerve cells supplying muscles in the leg are responsible and hereby additional drug treatments may be ahead targeting these nerve cells,” commented Dirk Czesnik--author of the study.

Researchers are hopeful that future drug developments will target the nerve cells that signal each other to reduce the number of messages being sent—ultimately, achieving normal levels of signaling that can prevent the occurrence of RLS symptoms.

These drugs will most likely inhibit the ion channels that are essential for nerve cell communication. However, further research is needed to investigate the effects of different compounds in patients with RLS.

Source: Journal of Physiology, ScienceDaily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
SEP 24, 2018
Drug Discovery
SEP 24, 2018
Pain Management Drug Found Ineffective in Traumatic Injury Patients
Driven by the effort to identify effective non-opioid pain medications, a recent international research study with a publication in the Journal Neurology, ...
OCT 02, 2018
Drug Discovery
OCT 02, 2018
Mycobacterial Lung Disease, FDA Approves New Drug
New drug seeking to treat antibiotic-resistant lung disease has just been approved by the U.S. Food and Drug Administration. The drug is called ‘Arik...
OCT 16, 2018
Neuroscience
OCT 16, 2018
Your brain tells if a placebo can treat pain
Placebo effect and predicting when a particular subject will have a placebo response by using as little as psychological questionnaires....
OCT 24, 2018
Drug Discovery
OCT 24, 2018
Silver Nanoparticles Coat Anti-seizure Drugs To Combat Brain-Eating Amoebae
Since Halloween is around the corner, it is science-fiction season and some may choose to celebrate by watching movies featuring brain-eating zombies. Howe...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
Loading Comments...